Platelet-activating factor antagonist-based intensive antiplatelet strategy in acute ischemic stroke: A propensity score matched with network pharmacology analysis.
Xiaoyan HanYoujia LiXuemin ChenDong PanJunning MoJiaming QiuYi LiYan ChenYan HuangQingyu ShenYamei TangPublished in: CNS neuroscience & therapeutics (2023)
An intensive antiplatelet strategy of DGMI plus traditional antiplatelet agents is effective in treating AIS and may work by mediating post-stroke inflammation and thrombosis.